China Centers for Disease Control and Prevention: No evidence to indicate that XBB mut

Experts from the China Centers for Disease Control and Prevention said that the Coronary Virus XBB mutant strains have not yet formed local popularity in China, and there is no evidence that the pathogenic force of XBB mutation strains has increased.

China Official Media People's Daily published an exclusive interview with Chen Cao, a researcher at the China Centers for Disease Control and Prevention Center on Saturday (January 14).Chen Cao said that from the results of a number of research, the evolution branch of XBB is the primitive strain and the previous concern of the previously discovered.The ability to increase significantly.This has also led to a significant increase in the communication advantage of XBB in the United States and other countries.

He said that from December 1st last year to January 12 this year, China only monitored the cases of infection of local XBB mutant plants; 33 input cases of XBB and its sub -branches were from 20Countries and regions.In the future or follow -up, China is facing the risk of entering XBB and its sub -branches, causing a greater risk of local related cases.But as far as the current monitoring data, XBB has not formed local popularity.

Chen Cao said that from the results of multiple studies, the evolution branch of XBB is the original strain that was initially discovered and the previous concerns of the mutant strains, such as the Delta mutant strains and Omikona's early early early days.The evolutionary branch discovered has a significant increase in immune escape.This has also led to a significant increase in the communication advantage of XBB in the United States and other countries.However, from the current reports and research, it has not been observed that the increase in the infected XBB series of mutant strains increased, that is, the pathogenic force has not increased significantly.

Liu Qingquan, Dean of Beijing Traditional Chinese Medicine Hospital, said in an interview that at present, information in international literature shows that there seems to be no significant difference between the clinical manifestations of the XBB mutant strain infection and the popular plants in China, and it is stillIt is mainly upper respiratory tract infection.China has not seen clinical cases.From the perspective of traditional Chinese medicine, XBB mutation plants are not very different from the current popular variable strains in China. The core diseases of traditional Chinese medicine are consistent, and the treatment plan is still available.